INFI - Infinity Pharmaceuticals beats by $0.36 November, 05 2018 04:24 PM Infinity Pharmaceuticals Inc. Infinity Pharmaceuticals (NASDAQ:INFI): Q3 GAAP EPS of $0.23 beats by $0.36. More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Consumer stocks news, , Read more ...